<DOC>
	<DOCNO>NCT02044575</DOCNO>
	<brief_summary>Despite large effort try improve diagnostic therapy sepsis make last decade ( e.g . initiation Surviving Sepsis Campaign , define evidence base sepsis therapy bundle ) mortality septic shock remain high cause high socioeconomical burden disease . The purpose pilot study evaluate design conduct project full scale clinical trial .</brief_summary>
	<brief_title>Clock Genes Patients With Refractory Septic Shock ( SeptiClock ) - Pilot Study</brief_title>
	<detailed_description>A functional clock require induction several proinflammatory gene , show septic patient setting , yet . Clock gene involve modulate activity several transcription factor important regulator immune function ( e.g . HIF1-α , STAT1 , STAT3 , NF-κB ) ( Bellet MM et al. , 2013 ) . Furthermore , polymorphisms rs7221412 , common polymorphism near period homolog 1 ( PER1 ) , associated timing activity rhythm also show suggestive time-dependent relationship cerebral cortex monocyte PER1 expression association time death ( Lim ASP et al. , 2012 ) . This explorative project pilot study . First data generate assessment circadian system patient septic shock .</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<criteria>Male female patient age 18 year , Patient intensive care unit ( 8i , 9i 1i Charité University Medicine Berlin , Campus Virchow Klinikum ) , Septic shock ( ACCP/SCCM ( American College Chest Physicians/Society Critical Care Medicine ) consensus definition ) , Randomization inclusion criterion : Presence sepsisassociated immunosuppression ( monocytic HLADR expression &lt; 10.000 molecule per cell ) AND Norepinephrine dosage &gt; 0.3 μg/kg/min least 2 hour Pregnant lactate female patient , Participation another interventional study ( 30 day study inclusion study participation ) , Acute leucemia , Severe leukocytosis ( &gt; 50,000/nl ) , Severe thrombocytopenia ( &lt; 5,000/nl ) , Autoimmune disease systemic medication ≥10 mg prednisolone equivalent previous transplantation , Patients receive interferon therapy ( last 14 day ) , Patients know hypersensitivity GMCSF know antibody GMCSF , yeastderived product component study medication , Ongoing ( concomitant ) chemotherapy radiotherapy malignancy , Acute pulmonary embolism acute myocardial infarction within last 72 hour , Cardiopulmonary resuscitation within last 7 day , Moribund patient ( life expectancy &lt; 72 hr . ) , Presence donotresuscitate donotintubate order , Known human immunodeficiency virus ( HIV ) infection chronic viral hepatitis Lacking willingness save hand data within study Accommodation institution due official judicial order The informed consent patient subject 's legally acceptable representative can´t obtain time Patient power attorney patient 's provision , he/she refuse participation clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Clock gene , circadian regulation</keyword>
</DOC>